cilostazol-based triple antiplatelet therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cilostazol-based triple antiplatelet therapy, covering 2019-01-14 to 2019-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study) [Phase 4]